C019199
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C019199, covering 2025-11-28 to 2025-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]